Anisodamine, an anticholinergic drug, has antishock effect, which is intimately linked to alpha7nAChR-dependent anti-inflammatory pathway. Anisodamine demonstrates a direct cardiac depressive action at the myocyte level, which may be related to, at least in part, NO production and cholinoceptor antagonism, it causes the changes of structure and function in the transmembrane domain of the Ca(2+)-ATPase from sarcoplasmic reticulum. Anisodamine, a vasoactive drug, can abate endogenous endotoxaemia subsequent to splanchnic vasoconstriction due to hypovolaemia, it alleviates inflammatory damage by significantly reducing the expressions of VEGF and ICAM-1, and shows significant protective effects in an animal model of infusion phlebitis. Anisodamine also inhibits shiga toxin type 2-mediated tumor necrosis factor-alpha production in vitro and in vivo. Scopolamine is a non subtype selective muscarinic and nicotinic acetylcholine receptor antagonist. Scopolamine is used in traditional Chinese medicine research for various diseases, mainly for improving microcirculation in shock state, and can also be used for organophosphate poisoning.

Allocryptopine is an aromatic ether, an organic heterotetracyclic compound, a dibenzazecine alkaloid, a cyclic ketone, a tertiary amino compound and a cyclic acetal. Allocryptopine has certain effects on anti-injury for hepatocyte, ameliorating liver function, and prohibiting hepatic fibrosis; it increases mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR. Allocryptopine induces a relaxing effect on the ileum by inhibiting phosphodiesterase enzyme, and thus elevating cellular cAMP and its contractile effect on the urinary bladder by affecting alpha-adrenergic receptors in this tissue, it can block human ether-a-go-go related gene (hERG) potassium channels expressed in HEK293 cells. Allocryptopine is a derivative of berberine extracted from Macleaya cordata. Allocryptopine has anti arrhythmic effects and can effectively block hERG currents.

Scopolamine hydrobromide is a non subtype selective antagonist of muscarinic and nicotinic cholinergic receptors. Scopolamine hydrobromide has antioxidant and anti-inflammatory activities.